Skajaa N, Adelborg K, Horvath-Puho E, Rothman KJ, Henderson VW, Thygesen LC, Sorensen HT. Stroke and risk of mental disorders compared with matched general population and Myocardial infarction comparators. Stroke. 2022 Jul;53(7):2287-98. doi: 10.1161/STROKEAHA.121.037740
Jeyakumar G, Tu JV, Austin PC, Hall R, Jin A, Manuel D, Silver FL, Swartz R, Chu A, Khan AM, Kapral MK. Rural-urban differences in stroke incidence, mortality and risk factor prevalence in Ontario. Poster presented at the American Heart Association/American Stroke Association 2017 International Stroke Conference; February 21, 2017. Houston, TX. [abstract] Stroke. 2017 Feb; 48(Suppl_1):180. doi: 10.1161/str.48.suppl_1.wp180
Bowater RJ, Hartley LC, Lilford RJ. Are cardiovascular trial results systematically different between North America and Europe? A study based on intra-meta-analysis comparisons. Arch Cardiovasc Dis. 2015 Jan;108(1):23-38. doi: 10.1016/j.acvd.2014.03.005
Shah S, Murthy S, Karanth S, Bershad EM, Venkatasubba Rao CP, Suarez JI. Treatment of ischemic stroke with recombinant tissue plasminogen-activator in pregnancy: a population study. Poster presented at the International Stroke Conference 2014; February 2014. San Diego, CA. [abstract] Stroke. 2014 Feb; 45(Suppl 1). doi: doi.org/10.1161/str.45.suppl_1.wp61Stroke. 2014;45:AWP61
Murthy S, Shah S, Karanth S, Shastri A, Bershad E, Suarez JI. Clinical outcomes following thrombolysis for acute ischemic stroke in patients with primary brain tumors: a nationwide population study. Poster presented at the International Stroke Conference 2014; February 2014. San Diego, CA. [abstract] Stroke. 2014 Feb; 45(Suppl 1). doi: 10.1161/str.45.suppl_1.tmp14Stroke. 2014;45:ATMP14
Murthy S, Shah S, Karanth S, Shastri A, Bershad E, Suarez JI. Clinical outcomes following thrombolysis for acute ischemic stroke in patients with systemic malignancy: a nationwide case-control study. Poster presented at the International Stroke Conference 2014; February 2014. San Diego, CA. [abstract] Stroke. 2014 Feb; 45(Suppl 1).
Murthy SB, Karanth S, Shah S, Shastri A, Rao CP, Bershad EM, Suarez JI. Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke. 2013 Dec;44(12):3573-6. doi: 10.1161/STROKEAHA.113.003058
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol. 2010 Apr 1;24(4):489-96.
Novick D, Reed C, Gonzalez-Pinto A, Aguado J, Haro JM. Comparison of olanzapine and valproate over 12 months of treatment in the emblem study. J Psychopharmacol. 2010;24:A54.
Earnshaw SR, Jackson D, Farkouh R, Schwamm L. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis. Stroke. 2009 May 1;40(5):1710-20.
Earnshaw SR, Jackson DL, Farkouh RA, Schwamm LH. Cost-effectiveness of MRI-based selection of patients for intravenous thrombolysis. Poster presented at the 2009 International Stroke Conference; February 2009. San Diego, CA. [abstract] Stroke. 2009 Apr; 40(4):E192-3.
Julvez J, Forns M, Ribas-Fito N, Mazon C, Torrent M, Garcia-Esteban R, Ellison-Loschmann L, Sunyer J. Psychometric characteristics of the California Preschool Social Competence Scale in a spanish population sample. Early Educ Dev. 2008;19(5):795-815.
Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication. J Psychopharmacol. 2007;21(Suppl):A39.
Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006 Nov 28;37(11):2751-8.
Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor vii in the treatment of intracerebral hemorrhage. Poster presented at the 2006 International Stroke Conference; February 17, 2006. [abstract] Stroke. 2006 Nov; 37(11):2751.
Fireman B, Mines D, Lee J, Hunkeler EM. The risk of suicide in patients treated with venlafaxine, fluoxetine, citalopram, or paroxetine at Kaiser Permanente in Northern California. Poster presented at the 2006 Summer Meeting of the British Association for Psychopharmacology; July 2006. Oxford, United Kingdom. [abstract] J Psychopharmacol. 2006 Sep; 20(5 Suppl):A58.
Strickland A, Brogan AJ, Krauss J, Martindale R, Cresci G. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enter Nutr. 2005 Jan 1;29(1 Suppl):S81-91.
Djousse L, Rothman KJ, Cupples LA, Arnett DK, Ellison RC. Relation between serum albumin and carotid atherosclerosis the NHLBI family heart study. Stroke. 2003 Jan 1;34(1):53-7.
Clarkson TB, Anthony MS, Mikkola TS, St. Clair RW. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Stroke. 2002 Nov;33(11):2700-3.